| Ms Connie Hall Strong, APRN | |
|
22 S State St, Clearfield, UT 84015-1043 | |
| (801) 525-4900 | |
| (801) 394-3693 |
| Full Name | Ms Connie Hall Strong |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health, Adult |
| Location | 22 S State St, Clearfield, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053398610 | NPI | - | NPPES |
| 262079 | Other | UT | U002 |
| 942938348ST5 | Other | UT | U003 |
| 942938348 | Other | UT | U009 |
| 004662127 | Other | UT | RCAR |
| 104472 | Other | UT | U005 |
| 107001407101 | Other | UT | U006 |
| 004662127 | Other | UT | ICAR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0809X | Clinical Nurse Specialist - Psychiatric/mental Health, Adult | 2137244405 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Connie Hall Strong, APRN 2240 Adams Ave, Ogden, UT 84401-1511 Ph: (801) 393-5355 | Ms Connie Hall Strong, APRN 22 S State St, Clearfield, UT 84015-1043 Ph: (801) 525-4900 |
News Archive
Physical function and sense of autonomy are independent determinants of life-space mobility in older people. This was found in a study conducted at the Gerontology Research Center of the University of Jyv-skyl-. In this project, 848 older men and women that lived independently in the Jyv-skyl- region in Central Finland were interviewed at their own home.
"Time poor" single mothers come surprisingly close in the number of hours they spend caring for their children compared to married mothers, and the difference is explained almost entirely by socio-economic factors and the kind of jobs they hold, say University of Maryland sociologists in a new study.
Chevy Chase, MD-Vitamin D-deficient older individuals are more likely to struggle with everyday tasks such as dressing or climbing stairs, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
Exelixis, Inc. today announced it has initiated METEOR, a phase 3 pivotal trial comparing cabozantinib to everolimus in patients with metastatic renal cell carcinoma who have experienced disease progression following treatment with at least one prior VEGFR tyrosine kinase inhibitor.
› Verified 9 days ago